{
    "relation": [
        [
            "Fund Name",
            "FMR",
            "OppenheimerFunds",
            "Franklin Resources",
            "Vanguard",
            "First Trust Advisors",
            "BlackRock Fund Advisors",
            "Jennison Associates",
            "BlackRock Institutional Trust Company, N.A.",
            "Columbia Wanger Asset Management",
            "LORD, ABBETT & CO",
            "HealthCor Management",
            "Frontier Capital Management",
            "SUSQUEHANNA INTERNATIONAL",
            "STATE STREET CORPORATION",
            "Millennium Management",
            "OrbiMed Advisors",
            "TimesSquare Capital Management",
            "BlackRock Advisors",
            "S.A.C. Capital Advisors",
            "First Eagle Investment Management",
            "Columbus Circle Investors",
            "Wellington Management Company",
            "HealthCor Management",
            "Sectoral Asset Management",
            "ALLIANCEBERNSTEIN",
            "TSP Capital Management",
            "Deutsche Bank Aktiengesellschaft"
        ],
        [
            "Number of Shares",
            "14.53M",
            "9.13M",
            "8.67M",
            "6.09M",
            "4.74M",
            "3.72M",
            "3.03M",
            "2.99M",
            "2.80M",
            "2.67M",
            "2.50M",
            "2.50M",
            "2.49M",
            "2.31M",
            "2.07M",
            "2.06M",
            "1.85M",
            "1.83M",
            "1.82M",
            "1.66M",
            "1.63M",
            "1.62M",
            "1.45M",
            "1.41M",
            "1.40M",
            "1.38M",
            "1.35M"
        ],
        [
            "Share Valuation",
            "$404.85M",
            "$254.32M",
            "$241.72M",
            "$169.74M",
            "$132.02M",
            "$103.65M",
            "$39.24M",
            "$83.34M",
            "$78.06M",
            "$48.72M",
            "$8.88M",
            "$62.94M",
            "$32.31M",
            "$64.41M",
            "$57.70M",
            "$37.64M",
            "$51.43M",
            "$28.55M",
            "$32.14M",
            "$8.62M",
            "$29.71M",
            "$25.26M",
            "$22.63M",
            "$24.90M",
            "$21.86M",
            "$9.27M",
            "$37.67M"
        ],
        [
            "As Of",
            "March 31, 2015",
            "March 31, 2015",
            "March 31, 2015",
            "March 31, 2015",
            "March 31, 2015",
            "March 31, 2015",
            "Sept. 30, 2014",
            "March 31, 2015",
            "March 31, 2015",
            "Dec. 31, 2014",
            "June 30, 2011",
            "June 30, 2015",
            "Sept. 30, 2014",
            "March 31, 2015",
            "March 31, 2015",
            "Dec. 31, 2014",
            "March 31, 2015",
            "June 30, 2013",
            "March 31, 2014",
            "June 30, 2012",
            "Dec. 31, 2014",
            "June 30, 2013",
            "June 30, 2013",
            "March 31, 2014",
            "June 30, 2013",
            "Dec. 31, 2012",
            "March 31, 2015"
        ]
    ],
    "pageTitle": "Who owns Celldex Therapeutics? 13F filings of top holders in CLDX - simplified 13F-HR filings at stockzoa",
    "title": "",
    "url": "http://stockzoa.com/ticker/cldx/",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 0,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042986625.58/warc/CC-MAIN-20150728002306-00323-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 228765370,
    "recordOffset": 228757168,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 29 Jul 2015 20:02:11 GMT",
    "textBeforeTable": "Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics. Who owns Celldex Therapeutics? Is CLDX overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on CLDX CUSIP: 15117B103 Key details on Celldex Therapeutics (Ticker: CLDX) Who owns Celldex Therapeutics? enable Javascript to navigate the interface properly. upgrade your browser or Javascript is disabled or is not supported by your browser. Please (adsbygoogle = window.adsbygoogle || []).push({});",
    "textAfterTable": "Who sold Celldex Therapeutics? Fund Name Date Sold Number of Shares Sold Share Valuation Ridgeback Capital Investments Dec. 31, 2012 3.80M $25.53M \u00a0 \u00a9 2011 stockzoa - Simplified 13F-HR Filings. Also check out Bonafide.",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}